Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery.

Abe J, Zhou W, Taguchi J, Takuwa N, Miki K, Okazaki H, Kurokawa K, Kumada M, Takuwa Y.

Biochem Biophys Res Commun. 1994 Jan 14;198(1):16-24.

PMID:
8292019
2.

Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty.

Wei GL, Krasinski K, Kearney M, Isner JM, Walsh K, Andrés V.

Circ Res. 1997 Mar;80(3):418-26.

PMID:
9048663
3.

Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.

Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.

J Clin Invest. 1994 Apr;93(4):1458-64.

4.

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.

Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8474-8.

6.

Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.

Herbert JM, Guy AF, Lamarche I, Mares AM, Savi P, Dol F.

J Cell Physiol. 1997 Feb;170(2):106-14.

PMID:
9009139
7.
8.

Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.

Takahashi A, Taniguchi T, Ishikawa Y, Yokoyama M.

Circ Res. 1999 Mar 19;84(5):543-50.

9.

Cdc25 regulates the phosphorylation and activity of the Xenopus cdk2 protein kinase complex.

Gabrielli BG, Lee MS, Walker DH, Piwnica-Worms H, Maller JL.

J Biol Chem. 1992 Sep 5;267(25):18040-6.

10.

Reconstitution of cyclin-dependent cdc2 and cdk2 kinase activities in vitro.

Pan ZQ, Hurwitz J.

J Biol Chem. 1993 Sep 25;268(27):20433-42.

11.

Simultaneous suppression of cdc2 and cdk2 activities induces neuronal differentiation of PC12 cells.

Dobashi Y, Shoji M, Kitagawa M, Noguchi T, Kameya T.

J Biol Chem. 2000 Apr 28;275(17):12572-80.

12.

A cdc2-related kinase oscillates in the cell cycle independently of cyclins G2/M and cdc2.

Gabrielli BG, Roy LM, Gautier J, Philippe M, Maller JL.

J Biol Chem. 1992 Jan 25;267(3):1969-75.

13.

G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.

O'Connor PM, Ferris DK, Pagano M, Draetta G, Pines J, Hunter T, Longo DL, Kohn KW.

J Biol Chem. 1993 Apr 15;268(11):8298-308.

14.

Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.

Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI.

J Clin Invest. 1994 Feb;93(2):820-8.

15.

Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.

Gu Y, Rosenblatt J, Morgan DO.

EMBO J. 1992 Nov;11(11):3995-4005.

16.

Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide.

Suzuki J, Isobe M, Morishita R, Aoki M, Horie S, Okubo Y, Kaneda Y, Sawa Y, Matsuda H, Ogihara T, Sekiguchi M.

Nat Med. 1997 Aug;3(8):900-3.

PMID:
9256282
17.

Cyclin-dependent kinase 2 (cdk2) in the murine Cdc2 kinase TS mutant.

Yasuda H, Nakata T, Kamijo M, Honda R, Nakamura M, Ninomiya-Tsuji J, Yamashita M, Nagahama Y, Ohba Y.

Somat Cell Mol Genet. 1992 Sep;18(5):403-8.

PMID:
1475706
19.

Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro.

Connell-Crowley L, Solomon MJ, Wei N, Harper JW.

Mol Biol Cell. 1993 Jan;4(1):79-92.

20.

Involvement of c-Jun NH2 terminal kinase and p38MAPK in rapamycin-mediated inhibition of neointimal formation in rat carotid arteries.

Omura T, Yoshiyama M, Izumi Y, Kim S, Matsumoto R, Enomoto S, Kusuyama T, Nishiya D, Nakamura Y, Akioka K, Iwao H, Takeuchi K, Yoshikawa J.

J Cardiovasc Pharmacol. 2005 Oct;46(4):519-25.

PMID:
16160607

Supplemental Content

Support Center